SCHEMBL8944610

SCHEMBL8944610

CCN1CCN(Cc2ccccc2Cl)C(C2=NCCN2)C1

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
SIGMAR1 Q99720 3/20 0.39
KDM4E B2RXH2 2/20 0.38
HTT P42858 1/20 0.38
TMEM97 Q5BJF2 2/20 0.38
ALDH1A1 P00352 1/20 0.37
PLA2G1B P04054 1/20 0.37
RAB9A P51151 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8944554 0.92 SIGMAR1 (0.44) KMT2ALMNASIGMAR1KDM4EHTT
SCHEMBL8944696 0.92 NISCH (0.41) KMT2ALMNASIGMAR1KDM4EHTT
SCHEMBL8944703 0.91 SIGMAR1 (0.41) KMT2ALMNASIGMAR1KDM4EHTT
SCHEMBL8944755 0.87 LMNA (0.40) KMT2ALMNA
SCHEMBL8944819 0.84 LMNA (0.38) KMT2ALMNAKDM4EHTT
SCHEMBL8944513 0.83 SIGMAR1 (0.44) KMT2ALMNASIGMAR1KDM4EHTT
SCHEMBL8944673 0.80 LMNA (0.41) KMT2ALMNA
SCHEMBL8944864 0.80 L3MBTL1 (0.42) KMT2ALMNASIGMAR1KDM4EHTT
SCHEMBL8944853 0.79 SIGMAR1 (0.44) SIGMAR1KDM4EALDH1A1
SCHEMBL8944902 0.78 CYP2A13 (0.39) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638568-B1 Substituted piperazines, their process of preparation and the pharmaceutical compositions containing them ADIR (FR) 1996-10-09 EP disclosed
US-5500426-A ADMINISTERED TO IMPROVE GLUCOSE TOLERANCE ADIR ET COMPAGNIE (FR) 1996-03-19 US disclosed
US-5492912-A IMPROVES GLUCOSE TOLERANCE ADIR ET COMPAGNIE (FR) 1996-02-20 US disclosed
EP-0638568-A1 Substituted piperazines, their process of preparation and the pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1995-02-15 EP disclosed